Drug Trial Radar · NCT02419001
A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy
Last checked: Nov 19, 2026Latest source record: Nov 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
11
Actual
Start
Mar 2015
Primary completion
Sep 2015
Study completion Oct 2015
Sponsor
- Lead sponsor
- Theriva Biologics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 17, 2015
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A Phase 1b/2a, Randomized, Multi-Center, Open-Label, Fixed-Sequence Study to Evaluate the Effect of Oral SYN-004 on the Pharmacokinetics of Intravenous Ceftriaxone in Healthy Adult Subjects with a Functioning Ileostomy.
Conditions
- Healthy Volunteers
Interventions
Period 1 - Treatment Sequence ABDrug
Period 1: Ceftriaxone 1 g infused IV over 30 minutes only, no SYN-004
Period 1 - Treatment Sequence ACDrug
Period 1: Ceftriaxone 1 g infused IV over 30 minutes only, no SYN-004
Period 2 - Treatment Sequence ABDrug
Period 2: Ceftriaxone 1 g infused IV over 30 minutes and SYN-004 75 mg
Period 2 - Treatment Sequence ACDrug
Period 2: Ceftriaxone 1 g infused IV over 30 minutes and SYN-004 150 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ceftriaxone PK Maximum Observed Plasma Concentration (Cmax) With (Period 2) and Without (Period 1) SYN-004.Time frame: 2 weeks
- Ceftriaxone PK Time to Reach Cmax (Tmax) With (Period 2) and Without (Period 1) SYN-004.Time frame: 2 weeks
- Ceftriaxone PK Area Under the Concentration-time Curve From Time 0 to the Last Quantifiable Concentration (AUCt) With (Period 2) and Without (Period 1) SYN-004.Time frame: 2 weeks
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
Site not named
Columbus, Ohio
Site not named
Montreal, Canada
Site not named
Edmonton, Alberta, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.